X-Vax is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.
Gameto
Series A • New York, United States
Neogene Therapeutics
Series A • New York, United States
Xontogeny
Series A • Boston, United States
Chroma Medicine
Series A • Cambridge, United States
Primmune Therapeutics
Series A • San Diego, United States
Kula Bio
Series A • Somerville, United States
Dianthus Therapeutics
Series A • Waltham, United States
Arcaea
Series A • Boston, United States
royal
Series A • Austin, United States
Callin
Series A • San Francisco, United States
Rewatch
Series A • San Francisco, United States
Opal
Series A • San Francisco, United States